We inform you about the current business development of HAEMATO AG and about our investor relations activities.
In today's meeting, the Supervisory Board of HAEMATO AG ("HAEMATO" or the "Company") accepted the wish of Dr. Christian Pahl to not extend his contract as Management Board Member beyond the current term ending 31 July 2017. The Supervisory Board regrets...read more
HAEMATO AG: Capital increase from authorized capital under exclusion of existing shareholders' subscription rights resolved and successfully implemented. The Management Board of HAEMATO AG, Schönefeld, (ISIN: DE0006190705) decided today with the approval...read more